Authors:
Malonne, H
Farinelle, S
Decaestecker, C
Gordower, L
Fontaine, J
Chaminade, F
Saucier, JM
Atassi, G
Kiss, R
Citation: H. Malonne et al., In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1, CLIN CANC R, 6(9), 2000, pp. 3774-3782
Authors:
Mee, SL
Chaminade, C
Delaporte, C
Markovits, J
Saucier, JM
Jacquemin-Sablon, A
Citation: Sl. Mee et al., Cellular resistance to the antitumor DNA topoisomerase II inhibitor S16020-2: Importance of the N-[2(dimethylamino)ethyl] carbamoyl side chain, MOLEC PHARM, 58(4), 2000, pp. 709-718
Authors:
Khelifa, T
Rene, B
Le Mee, S
Lambert, B
Saucier, JM
Markovits, J
Jacquemin-Sablon, H
Jacquemin-Sablon, A
Citation: T. Khelifa et al., Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblastswith human topoisomerase II alpha cDNA: Selective restoration of the sensitivity to DNA religation inhibitors, CANCER RES, 59(19), 1999, pp. 4927-4936